Salus
ISIN: SI0031110453 | Ticker: SALR | LEI: 4851000025STPWS61L07
Country: Slovenia
Since the Salus Group is specialised to provide complete distribution, promotion and active sales services as well as value added services necessary for the medicinal product or medical device to be placed on the market it represents a vital link in the supply of medicinal products, dietary supplements, medical devices and high-quality and innovative services, which provide health and well-being of people. Regionally, the Salus Group is present on the markets of Central and Eastern Europe.
Year founded1969
Served areaEurope
HeadquartersLitostrojska cesta 46 A, 1000 Ljubljana – Slovenia
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 146,341,970.00 | 169,116,984.00 | 174,629,198.00 |
| Noncurrent Assets | N/A | 43,549,895.00 | 45,731,748.00 | 50,681,744.00 |
| Property Plant And Equipment | N/A | 29,651,606.00 | 33,279,879.00 | 39,089,135.00 |
| Investment Property | N/A | 2,766,123.00 | 1,664,024.00 | 1,645,057.00 |
| Goodwill | N/A | 1,870,087.00 | 1,870,087.00 | 1,870,087.00 |
| Intangible Assets Other Than Goodwill | N/A | 7,536,017.00 | 7,263,865.00 | 6,550,952.00 |
| Investments In Subsidiaries | N/A | 0.00 | 0.00 | 0.00 |
| Investments In Associates | N/A | 43,128.00 | 52,526.00 | 66,676.00 |
| Noncurrent Receivables | N/A | 95,482.00 | 12,349.00 | 17,137.00 |
| Deferred Tax Assets | N/A | 446,962.00 | 303,685.00 | 93,805.00 |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss | N/A | 1,026,542.00 | 1,187,330.00 | 1,084,817.00 |
| Noncurrent Financial Assets At Amortised Cost | N/A | 54,758.00 | 33,099.00 | 211,290.00 |
| Other Noncurrent Nonfinancial Assets | N/A | 59,190.00 | 64,904.00 | 52,788.00 |
| Current Assets | N/A | 102,792,075.00 | 123,385,236.00 | 123,947,454.00 |
| Inventories | N/A | 38,737,401.00 | 43,431,501.00 | 46,044,227.00 |
| Trade And Other Current Receivables | N/A | 52,015,796.00 | 55,708,719.00 | 55,145,720.00 |
| Current Tax Assets Current | N/A | 18,885.00 | 16,627.00 | 328,555.00 |
| Current Financial Assets At Amortised Cost | N/A | 43,824.00 | 21,667.00 | 342,253.00 |
| Cash and cash equivalents | 14,337,438.00 | 8,821,103.00 | 17,652,227.00 | 19,115,345.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | N/A | 0.00 | 947,587.00 | 0.00 |
| Current Prepayments And Other Current Assets | N/A | 2,903,632.00 | 3,525,561.00 | 2,760,896.00 |
| Equity And Liabilities | N/A | 146,341,970.00 | 169,116,984.00 | 174,629,198.00 |
| Equity | 54,593,082.00 | 60,034,306.00 | 67,335,074.00 | 73,846,056.00 |
| Issued Capital | N/A | 435,550.00 | 435,550.00 | 435,550.00 |
| Retained Earnings | N/A | 40,252,345.00 | 44,651,476.00 | 50,868,876.00 |
| Noncurrent Liabilities | N/A | 10,739,765.00 | 10,354,789.00 | 14,000,201.00 |
| Noncurrent Provisions | N/A | 1,130,105.00 | 1,084,947.00 | 1,069,988.00 |
| Noncurrent Payables | N/A | 0.00 | 0.00 | 0.00 |
| Noncurrent Retention Payables | N/A | 41,551.00 | 7,607.00 | 4,012.00 |
| Noncurrent Financial Liabilities At Amortised Cost | N/A | 9,568,109.00 | 9,262,235.00 | 12,926,201.00 |
| Current Liabilities | N/A | 75,567,899.00 | 91,427,121.00 | 86,782,941.00 |
| Trade And Other Current Payables | N/A | 67,068,113.00 | 81,792,634.00 | 80,285,459.00 |
| Current Tax Liabilities Current | N/A | 1,235,355.00 | 703,173.00 | 214,474.00 |
| Current Financial Liabilities At Amortised Cost | N/A | 3,598,842.00 | 3,253,980.00 | 3,470,876.00 |
| Current Accrued Expenses And Other Current Liabilities | N/A | 2,356,984.00 | 3,483,389.00 | 2,282,490.00 |
| Other Current Liabilities | N/A | 1,308,605.00 | 2,193,945.00 | 529,642.00 |
| Line item in (eur) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 400,668,529.00 | 458,281,575.00 | 495,670,814.00 |
| Other Income | 799,977.00 | 292,780.00 | 3,250,069.00 |
| Profit Loss From Operating Activities | 12,257,188.00 | 15,279,916.00 | 15,960,994.00 |
| Finance Income | 960,025.00 | 869,936.00 | 770,173.00 |
| Finance Costs | 632,097.00 | 317,527.00 | 511,512.00 |
| Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 | N/A | 298,344.00 | 521,287.00 |
| Profit Loss Before Tax | 12,596,760.00 | 16,373,331.00 | 16,412,199.00 |
| Profit (loss) | 10,130,643.00 | 13,005,742.00 | 13,095,092.00 |
| Line item in (eur) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | 10,130,643.00 | 13,005,742.00 | 13,095,092.00 |
| Adjustments For Income Tax Expense | N/A | 2,466,117.00 | 3,367,589.00 | 3,317,107.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -6,225,549.00 | -4,702,355.00 | -2,751,890.00 |
| Adjustments For Provisions | N/A | -170,824.00 | -32,694.00 | 186,322.00 |
| Adjustments For Fair Value Gains Losses | N/A | -41,836.00 | -170,552.00 | 102,513.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | N/A | -19,858.00 | -51,722.00 | -2,293,686.00 |
| Cash Flows From Used In Operating Activities | N/A | 5,297,631.00 | 22,899,140.00 | 11,625,331.00 |
| Other Cash Receipts From Sales Of Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | N/A | 162,928.00 | 0.00 | 0.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 409,307.00 | 615,097.00 | 285,527.00 |
| Cash Advances And Loans Made To Other Parties Classified As Investing Activities | N/A | 17,011.00 | 0.00 | 525,000.00 |
| Cash Receipts From Repayment Of Advances And Loans Made To Other Parties Classified As Investing Activities | N/A | 14,353.00 | 44,182.00 | 32,722.00 |
| Dividends Received Classified As Investing Activities | N/A | 15,286.00 | 24,666.00 | 33,750.00 |
| Interest Received Classified As Investing Activities | N/A | 3,985.00 | 1,427.00 | 9,233.00 |
| Cash Flows From Used In Investing Activities | N/A | -3,503,535.00 | -4,476,608.00 | 284,287.00 |
| Payments From Changes In Ownership Interests In Subsidiaries | N/A | 0.00 | 0.00 | 0.00 |
| Proceeds From Issuing Shares | N/A | 0.00 | 0.00 | 0.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 23,166,269.00 | 43,495,543.00 | 15,800,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | N/A | 24,592,218.00 | 46,053,881.00 | 18,010,698.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 928,141.00 | 1,079,492.00 | 1,216,859.00 |
| Dividends Paid Classified As Financing Activities | N/A | 4,696,875.00 | 5,740,625.00 | 6,784,375.00 |
| Cash Flows From Used In Financing Activities | N/A | -7,301,994.00 | -9,595,704.00 | -10,434,384.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -5,507,898.00 | 8,826,828.00 | 1,475,234.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -8,437.00 | 4,296.00 | -12,116.00 |
| Cash and cash equivalents | 14,337,438.00 | 8,821,103.00 | 17,652,227.00 | 19,115,345.00 |
Please note that some sums might not add up.
SI0031110453
LEI4851000025STPWS61L07
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.